I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
First-line camrelizumab (a PD-1 inhibitor) plus apatinib (a..:
Chen, Xiaofeng
;
Xu, Hao
;
Chen, Xiaobing
...
Signal Transduction and Targeted Therapy. 9 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/s41392-024-01773-9
RT Journal T1
First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study
UL https://suche.suub.uni-bremen.de/peid=cr-10.1038_s41392-024-01773-9&Exemplar=1&LAN=DE A1 Chen, Xiaofeng A1 Xu, Hao A1 Chen, Xiaobing A1 Xu, Tongpeng A1 Tian, Yitong A1 Wang, Deqiang A1 Guo, Fen A1 Wang, Kangxin A1 Jin, Guangfu A1 Li, Xiao A1 Wang, Rong A1 Li, Fengyuan A1 Ding, Yongbin A1 Tang, Jie A1 Fang, Yueyu A1 Zhao, Jing A1 Liu, Liang A1 Ma, Ling A1 Meng, Lijuan A1 Hou, Zhiguo A1 Zheng, Rongrong A1 Liu, Yang A1 Guan, Ni A1 Zhang, Bei A1 Tong, Shuang A1 Chen, Shiqing A1 Li, Xing A1 Shu, Yongqian PB Springer Science and Business Media LLC YR 2024 SN 2059-3635 JF Signal Transduction and Targeted Therapy VO 9 IS 1 LK http://dx.doi.org/https://doi.org/10.1038/s41392-024-01773-9 DO https://doi.org/10.1038/s41392-024-01773-9 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)